Clinical Trial Update: Study of SPG302 in Adults With Schizophrenia [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update for SPG302 in adults with schizophrenia; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• SPG302

Snippet

Sponsor: Spinogenix | Conditions: Schizophrenia | Phase 2 | Status: ACTIVE_NOT_RECRUITING